Jorge Matias-Guiu
Overview
Explore the profile of Jorge Matias-Guiu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
1744
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohamed-Fathy Kamal O, Ojeda-Hernandez D, Selma-Calvo B, Benito-Martin M, Fuente-Martin S, Garcia-Martin M, et al.
J Integr Neurosci
. 2025 Feb;
24(2):26429.
PMID: 40018775
Background: Multiple sclerosis (MS) is a neurodegenerative disorder characterized by progressive motor and cognitive impairments, affecting millions worldwide. It significantly reduces patients' quality of life and imposes a burden on...
2.
Moral-Rubio C, Suarez-Coalla P, Fernandez-Romero L, Perez-Izquierdo C, Delgado-Alvarez A, Delgado-Alonso C, et al.
J Alzheimers Dis
. 2025 Feb;
:13872877251315182.
PMID: 39994984
Background: Non-invasive brain stimulation has shown positive results in maximizing the effects of language therapy in primary progressive aphasia (PPA). Due to the different patterns of brain damage in each...
3.
Oliver-Mas S, Matias-Guiu J, Delgado-Alonso C, Cuevas C, Alcala Ramirez Del Puerto J, Lopez-Carbonero J, et al.
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941623
Fatigue is a prevalent and debilitating symptom in Post-COVID Condition (PCC), fibromyalgia, and multiple sclerosis (MS). Although these conditions share clinical similarities, the underlying mechanisms of fatigue across these conditions...
4.
Diez-Cirarda M, Yus-Fuertes M, Delgado-Alonso C, Gil-Martinez L, Jimenez-Garcia C, Gil-Moreno M, et al.
Mol Psychiatry
. 2025 Jan;
PMID: 39815057
Patients with post-COVID condition (PCC) present with diverse symptoms which persist at long-term after SARS-CoV-2 infection. Among these symptoms, cognitive impairment is one of the most prevalent and has been...
5.
Diaz-Alvarez J, Garcia-Gutierrez F, Bueso-Inchausti P, Cabrera-Martin M, Delgado-Alonso C, Delgado-Alvarez A, et al.
Cortex
. 2025 Jan;
183:309-325.
PMID: 39793260
Background: This study aimed to evaluate the capacity of neuropsychological assessment to predict the regional brain metabolism in a cohort of patients with amnestic Alzheimer's disease (AD) and behavioral variant...
6.
Matias-Guiu J, Alvarez-Sabin J, Botia E, Casado-Naranjo I, Castellanos M, Frank A, et al.
J Alzheimers Dis
. 2024 Nov;
102(1):207-217.
PMID: 39497319
Background: A deep knowledge of the healthcare system and the organization of neurology departments is important for planning and optimizing changes to facilitate the successful implementation of anti-amyloid antibodies treatments....
7.
Fernandez-Romero L, Morello-Garcia F, Laforce Jr R, Delgado-Alonso C, Delgado-Alvarez A, Gil-Moreno M, et al.
J Alzheimers Dis
. 2024 Nov;
102(1):67-76.
PMID: 39497317
Background: Clinical diagnosis in primary progressive aphasia (PPA) is challenging. Recently, emphasis has been placed on the importance of screening evaluation. Three different screening tests that use different strategies based...
8.
Delgado-Alvarez A, Hernandez-Lorenzo L, Rune Nielsen T, Diez-Cirarda M, Cuevas C, Montero-Escribano P, et al.
Mult Scler Relat Disord
. 2024 Oct;
91:105907.
PMID: 39366169
Background: The European Cross-Cultural Neuropsychological Test Battery (CNTB) has been proposed as a comprehensive battery for cognitive assessment, reducing the potential impact of cultural variables. In this validation study, we...
9.
Ojeda-Hernandez D, Velasco-Lozano S, Fraile J, Mateos-Diaz J, Rojo F, Benito-Martin M, et al.
Acta Biomater
. 2024 Sep;
188:157-168.
PMID: 39245308
Cell therapy is a promising strategy for treating neurological pathologies but requires invasive methods to bypass the blood-brain barrier restrictions. The nose-to-brain route has been presented as a direct and...
10.
Delgado-Alvarez A, Valles-Salgado M, Delgado-Alonso C, Matias-Guiu J, Matias-Guiu J
Brain Behav
. 2024 Sep;
14(9):e3650.
PMID: 39219244
Introduction: Despite the Rowland Universal Dementia Assessment Scale (RUDAS) having significant advantages as a cognitive screening tool, particularly for minority populations, the Mini-Mental State Examination (MMSE) test is the most...